HCA Healthcare, Inc. $HCA Shares Purchased by Russell Investments Group Ltd.

Russell Investments Group Ltd. lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 23.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 653,234 shares of the company’s stock after acquiring an additional 122,894 shares during the period. Russell Investments Group Ltd. owned approximately 0.31% of HCA Healthcare worth $278,823,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in HCA. MidFirst Bank bought a new stake in shares of HCA Healthcare in the second quarter valued at about $28,000. Clearstead Trust LLC bought a new position in shares of HCA Healthcare during the second quarter worth about $29,000. Latitude Advisors LLC acquired a new stake in HCA Healthcare in the 3rd quarter valued at approximately $32,000. Delos Wealth Advisors LLC bought a new stake in HCA Healthcare in the 2nd quarter valued at approximately $35,000. Finally, Laurel Wealth Advisors LLC acquired a new position in HCA Healthcare during the 3rd quarter worth approximately $40,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 1.1%

Shares of HCA Healthcare stock opened at $500.59 on Friday. The stock has a market cap of $104.57 billion, a P/E ratio of 16.59, a P/E/G ratio of 1.69 and a beta of 1.11. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The business’s 50 day moving average is $451.01 and its 200-day moving average is $445.95.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, beating the consensus estimate of $6.65 by $0.57. The business had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The firm’s revenue was up 3.6% on a year-over-year basis. During the same period last year, the business earned $6.96 earnings per share. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 30.15 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Stockholders of record on Tuesday, December 15th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 10.34%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael Schlosser sold 1,200 shares of the business’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $494.65, for a total transaction of $593,580.00. Following the transaction, the executive vice president directly owned 1,443 shares in the company, valued at $713,779.95. The trade was a 45.40% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Jon Foster sold 21,713 shares of the firm’s stock in a transaction dated Friday, November 6th. The shares were sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the completion of the sale, the chief operating officer owned 10,000 shares of the company’s stock, valued at $4,949,500. This trade represents a 68.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 36,413 shares of company stock worth $18,251,464 in the last ninety days. Insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of a number of recent research reports. Leerink Partners reiterated an “outperform” rating and issued a $492.00 price objective on shares of HCA Healthcare in a report on Friday, September 18th. BMO Capital Markets initiated coverage on shares of HCA Healthcare in a report on Tuesday, September 22nd. They set an “outperform” rating and a $495.00 target price for the company. Royal Bank Of Canada raised their target price on shares of HCA Healthcare from $496.00 to $521.00 and gave the company an “outperform” rating in a research report on Friday, October 30th. Oppenheimer cut their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research report on Monday, July 27th. Finally, UBS Group reduced their price objective on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research note on Monday, July 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $480.13.

View Our Latest Report on HCA

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.